Related Experiment Video
Updated: Apr 16, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Autoimmune hepatitis: East meets west.
Fan Yang1, Qixia Wang1, Zhaolian Bian1
1State Key Laboratory of Oncogenes and Related Genes, Key Laboratory of Gastroenterology & Hepatology, Ministry of Health, Division of Gastroenterology and Hepatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Cancer Institute, Shanghai Institute of Digestive Disease, Shanghai, China.
This review compares autoimmune hepatitis (AIH) in Eastern and Western countries, finding lower prevalence in Asia but more severe disease in Western patients. Early cirrhosis and poor treatment response predict a worse prognosis for AIH.
Area of Science:
- Hepatology
- Immunology
- Gastroenterology
Background:
- Autoimmune hepatitis (AIH) is a chronic inflammatory liver condition with varied clinical presentations.
- AIH predominantly affects females and has a global distribution.
Purpose of the Study:
- To compare epidemiological, genetic, clinical, and prognostic factors of AIH between Eastern and Western populations.
- To evaluate diagnostic accuracy of AIH criteria across different ethnicities.
- To identify predictors of poor prognosis in AIH patients.
Main Methods:
- Comparative review of AIH epidemiology, genetics, clinical features, and outcomes.
- Analysis of diagnostic criteria accuracy in diverse populations.
- Identification of prognostic factors for AIH.
Main Results:
- AIH prevalence and incidence are lower in the Asia-Pacific region compared to Europe and America.
- Western patients exhibit more severe disease, including younger age at diagnosis, higher rates of cirrhosis, elevated immunoglobulin G, and specific human leukocyte antigen (HLA) associations.
- Diagnostic accuracy of revised AIH criteria is comparable across populations. Cirrhosis at presentation and lack of response to immunosuppression within one year are key predictors of poor outcomes.
Conclusions:
- Significant geographical disparities exist in AIH presentation and severity.
- Established diagnostic criteria demonstrate cross-ethnic validity.
- Early identification of cirrhosis and monitoring treatment response are crucial for managing AIH prognosis.
Related Concept Videos
Hepatitis
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Gastritis-I: Introduction and Types
Acute gastritis presents as a sudden inflammation triggered by various stressors to the stomach lining, such as exposure to corrosive agents, local irritants like aspirin and other NSAIDs, alcohol consumption, radiation therapy, physical trauma, severe burns, sepsis,...

